Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Durie

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
Blood Advances|August 19, 2025
Next-generation flow cytometry analysis of clonal bone marrow plasma cells identifies an indolent subset of MGUSJon Thorir Oskarsson, Sigrún Thorsteinsdóttir, Sæmundur Rögnvaldsson, et al.
Haematologica|April 17, 2025
Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison studyTakeshi Yoroidaka, Hiroyuki Takamatsu, Ryota Urushihara, et al.
The Lancet Regional Health. Western Pacific|June 19, 2025
Imaging in plasma cell disorders-consensus recommendations of the Asian myeloma network bone imaging workgroupChandramouli Nagarajan, Natasha Fay Anthony, Jens Hillengass, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 27, 2024
Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the Connect<sup>Ⓡ</sup> MM RegistryHoward R Terebelo, James Omel, Lynne I Wagner, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 8, 2020
Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM RegistrySundar Jagannath, Robert M Rifkin, Cristina J Gasparetto, et al.
Leukemia|October 4, 2012
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative projectH Avet-Loiseau, B G M Durie, M Cavo, et al.
Blood Cancer Journal|December 18, 2024
The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance: a flow cytometry sub-study of the iStopMM screening studyJón Þórir Óskarsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone diseaseEvangelos Terpos, Gareth Morgan, Meletios A Dimopoulos, et al.
Leukemia|May 30, 2008
The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus StatementM A Hussein, F D Vrionis, R Allison, et al.
The Lancet. Oncology|February 5, 2021
Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working GroupEvangelos Terpos, Elena Zamagni, Suzanne Lentzsch, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Blood Advances|August 19, 2025
Next-generation flow cytometry analysis of clonal bone marrow plasma cells identifies an indolent subset of MGUSJon Thorir Oskarsson, Sigrún Thorsteinsdóttir, Sæmundur Rögnvaldsson, et al.
Haematologica|April 17, 2025
Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison studyTakeshi Yoroidaka, Hiroyuki Takamatsu, Ryota Urushihara, et al.
The Lancet Regional Health. Western Pacific|June 19, 2025
Imaging in plasma cell disorders-consensus recommendations of the Asian myeloma network bone imaging workgroupChandramouli Nagarajan, Natasha Fay Anthony, Jens Hillengass, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 27, 2024
Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the Connect<sup>Ⓡ</sup> MM RegistryHoward R Terebelo, James Omel, Lynne I Wagner, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 8, 2020
Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM RegistrySundar Jagannath, Robert M Rifkin, Cristina J Gasparetto, et al.
Leukemia|October 4, 2012
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative projectH Avet-Loiseau, B G M Durie, M Cavo, et al.
Blood Cancer Journal|December 18, 2024
The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance: a flow cytometry sub-study of the iStopMM screening studyJón Þórir Óskarsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone diseaseEvangelos Terpos, Gareth Morgan, Meletios A Dimopoulos, et al.
Leukemia|May 30, 2008
The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus StatementM A Hussein, F D Vrionis, R Allison, et al.
The Lancet. Oncology|February 5, 2021
Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working GroupEvangelos Terpos, Elena Zamagni, Suzanne Lentzsch, et al.
Pageof 15